Keywords: merck, singulair, cuts, inhaled, steroid, use, study

Merck's Singulair cuts inhaled steroid use

Article | 22 July 1999

Print This

A study of Merck & Co's Singulair (montelukast) plus inhaledsteroids in chronic asthma has demonstrated that patients were able to reduce ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in